should we consider interim analyzes when computing the sample size of a phase III trial? or the sample is calculated upfront and the alpha is just adjusted for the interim analyzes, not influencing the final sample?

if anyone could give reference of publications, it would be great

thank you!

More Rachel Riechelmann's questions See All
Similar questions and discussions